Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

World Orthopedic Drug Market Expected to Surge Past $44 Billion by 2010

By Pharmaceutical Processing | November 13, 2006

With gains expected to continue in all segments of the orthopedic drug market, new research estimates the global market, which totaled $26.8 billion in 2005, will surge past $44 billion in 2010.According to The Worldwide Market for Prescription Orthopedic Drugs, a new report from market research firm Kalorama Information, the arthritis treatment segment shows the greatest potential for rapid growth, with sales expected to increase by 15.8%. In fact, 2006 sales are expected to grow by more than 25% over 2005, when sales fell from the previous year largely due to the withdrawal of Vioxx and Bextra from the market and the suspension of direct- to-consumer advertising of select products including Celebrex.As the world’s aging population continues to increase, the demand for therapeutics to treat a wide range of orthopedic conditions such as osteoporosis, Paget’s disease, and other bone loss and growth disorders is mounting. Generics are creeping into some sectors which until recently were brand-only, heightening competitive pressures within the market. Yet the anticipated approval of many promising products leaves the market wide open for healthy growth.”The arthritis segment alone shows an enormous potential for breakthrough drugs with more than 75 drugs currently in the pipeline, many at the Phase III level,” notes Melissa Elder, the report’s author. “For example, MabThera, a groundbreaking new drug for rheumatoid arthritis sufferers, gained EU approval in May 2006 and is currently in Phase III in the U.S. This and other advancements in biologics-as well as advanced delivery methods and more targeted diagnostic methodologies-are going to continue to foster rapid industry-wide growth.”

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE